Mehrdad Hefazi

Publications

• Targeting Cancer-Associated Fibroblasts in the Bone Marrow Prevents Resistance to CART-Cell Therapy in Multiple Myeloma
  Blood. Jan, 2022  |   Pubmed ID: 35090171
• A Novel Iowa-Mayo Validated Composite Risk Assessment Tool for Allogeneic Stem Cell Transplantation Survival Outcome Prediction
  Blood Cancer Journal. 11, 2021  |   Pubmed ID: 34802042
• Emerging Approaches to Improve Allogeneic Hematopoietic Cell Transplantation Outcomes for Non-malignant Diseases
  Blood. Oct, 2021  |   Pubmed ID: 34614174
• Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
  International Journal of Molecular Sciences. Sep, 2021  |   Pubmed ID: 34575843
• Ruxolitinib Resistance or Intolerance in Steroid-refractory Acute Graft-versus-host Disease - a Real-world Outcomes Analysis
  British Journal of Haematology. 11, 2021  |   Pubmed ID: 34254289
• Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity
  Cancer Immunology Research. 09, 2021  |   Pubmed ID: 34244299
• Multi-institutional Study Evaluating Clinical Outcome with Allogeneic Hematopoietic Stem Cell Transplantation After Blinatumomab in Patients with B-cell Acute Lymphoblastic Leukemia: Real-world Data
  Bone Marrow Transplantation. 08, 2021  |   Pubmed ID: 33824440
• Resistance to CART Cell Therapy: Lessons Learned from the Treatment of Hematological Malignancies
  Leukemia & Lymphoma. 09, 2021  |   Pubmed ID: 33682608
• Leukemic Extracellular Vesicles Induce Chimeric Antigen Receptor T cell Dysfunction in Chronic Lymphocytic Leukemia
  Molecular Therapy : the Journal of the American Society of Gene Therapy. 04, 2021  |   Pubmed ID: 33388419
• Sequencing of Novel Agents in Relapsed/refractory B-cell Acute Lymphoblastic Leukemia: Blinatumomab and Inotuzumab Ozogamicin May Have Comparable Efficacy As First or Second Novel Agent Therapy in Relapsed/refractory Acute Lymphoblastic Leukemia
  Cancer. 04, 2021  |   Pubmed ID: 33259056
• Cardiovascular Outcomes in Patients Receiving Myeloablative Vs. Reduced Intensity Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
  Bone Marrow Transplantation. 02, 2021  |   Pubmed ID: 32772045
• Bone Marrow Dendritic Cell Aggregates Associate with Systemic Immune Dysregulation in Chronic Myelomonocytic Leukemia
  Blood Advances. 11, 2020  |   Pubmed ID: 33152058
• Real-world Outcomes of Adult B-cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab
  Blood Advances. 05, 2020  |   Pubmed ID: 32453836
• Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin
  Clinical Lymphoma, Myeloma & Leukemia. 08, 2020  |   Pubmed ID: 32291234
• Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 07, 2019  |   Pubmed ID: 31170029
• Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant
  Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. 06, 2019  |   Pubmed ID: 30772513
• GM-CSF Inhibition Reduces Cytokine Release Syndrome and Neuroinflammation but Enhances CAR-T Cell Function in Xenografts
  Blood. Feb, 2019  |   Pubmed ID: 30463995
• Recent Advances in the Biology and Treatment of B-cell Acute Lymphoblastic Leukemia
  Blood and Lymphatic Cancer : Targets and Therapy. 2018  |   Pubmed ID: 31360093
• The Association of De Novo Anti-HLA-DPB1 Donor-specific Antibody Formation and Primary Graft Failure After Allogeneic Hematopoietic Cell Transplantation
  Human Immunology. Dec, 2018  |   Pubmed ID: 30142360
• Non-internal Tandem Duplication (ITD), Non-tyrosine Kinase Domain (TKD) FLT3 Mutations in Myeloid Malignancies: A Brief Report of 10 Patients
  Leukemia Research. 09, 2018  |   Pubmed ID: 30055376
• Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia
  Current Hematologic Malignancy Reports. 08, 2018  |   Pubmed ID: 29948644
• Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome Without Significantly Impacting Measured Pulmonary Functions
  Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Sep, 2018  |   Pubmed ID: 29679771
• Thyroid Dysfunction in Adult Hematopoietic Cell Transplant Survivors: Risks and Outcomes
  Bone Marrow Transplantation. 08, 2018  |   Pubmed ID: 29410547
• Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series
  Mayo Clinic Proceedings. 11, 2017  |   Pubmed ID: 29101931
• Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease
  Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Sep, 2017  |   Pubmed ID: 28495641
• Vancomycin-resistant Enterococcus Colonization and Bloodstream Infection: Prevalence, Risk Factors, and the Impact on Early Outcomes After Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia
  Transplant Infectious Disease : an Official Journal of the Transplantation Society. Dec, 2016  |   Pubmed ID: 27642723
• Fludarabine-Busulfan Reduced-Intensity Conditioning in Comparison with Fludarabine-Melphalan Is Associated with Increased Relapse Risk In Spite of Pharmacokinetic Dosing
  Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. 08, 2016  |   Pubmed ID: 27164061
• ABO Blood Group Incompatibility As an Adverse Risk Factor for Outcomes in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia Undergoing HLA-matched Peripheral Blood Hematopoietic Cell Transplantation After Reduced-intensity Conditioning
  Transfusion. Feb, 2016  |   Pubmed ID: 26446051
• Prognostic Impact of Combined NPM1+/FLT3- Genotype in Patients with Acute Myeloid Leukemia with Intermediate Risk Cytogenetics Stratified by Age and Treatment Modalities
  Leukemia Research. Sep, 2015  |   Pubmed ID: 26410460